期刊论文详细信息
BMC Psychiatry
Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study
Lingjiang Li2  Li Zhang1  Yan Zhang1  Bangshan Liu1 
[1] Mental Health Institute of The Second Xiangya Hospital, National Technology Institute of Psychiatry,Key Laboratory of Psychiatry and Mental Health of Hunan Province, Central South University, Changsha, Hunan, China;Shenzhen Kangning Hospital of Guangdong Province, Shenzhen, Guangdong, China
关键词: Treatment-resistant;    Depression;    Transcranial magnetic stimulation;   
Others  :  1091795
DOI  :  10.1186/s12888-014-0342-4
 received in 2014-05-13, accepted in 2014-11-18,  发布年份 2014
PDF
【 摘 要 】

Background

Dozens of randomized controlled trials (RCTs) and meta-analyses have demonstrated the efficacy of repetitive transcranial magnetic stimulation (rTMS) for major depressive disorder (MDD) treatment, but there has not been a meta-analysis report which evaluates the efficacy and tolerability of rTMS used as an augmentative strategy for antidepressants in treatment-resistant depression (TRD) treatment. We thus conducted this meta-analysis, aimed at clarifying whether rTMS enhances the efficacy of TRD.

Methods

We searched MEDLINE and Cochrane Central Register of Controlled Trials for RCTs for studying the efficacy of rTMS versus (vs) sham condition when combined with antidepressants in TRD treatment, and screened the references of the previous meta-analysis about the rTMS for MDD treatment. Response rates and NNT were chose as the primary outcomes, and remission rates, change from baseline of HAMD scores, dropouts were used as secondary outcomes. For dichotomous data, an intention-to-treat analysis principle was applied; for continuous data, we calculated the standard mean difference between groups with a random-effect model. Sensitivity analysis was done to explore the source of heterogeneity and the factors which potentially impact the efficacy.

Results

Seven RCTs were finally included in the meta-analysis. The total sample size was 279, with 171 in the rTMS group and 108 in the sham group. The pooled response and remission rate for the rTMS and sham group was 46.6% and 22.1%, respectively; the pooled odds ratio (OR) was 5.12 [95% confidence interval (CI) 2.11-12.45, z = 3.60, p = 0.0003, and the associated number needed to treat (NNT) was 3.4. rTMS group achieved a significant reduction of HAMD score than the sham group, the pooled SMD of change from baseline was 0.86 [95% confidence interval (CI) 0.57-1.15, z = 5.75, p < 0.00001]. Because of the small number of included RCTs, the preplanned sensitivity and subgroup analyses were finally abandoned. The dropouts in both groups were relatively low, indicating the high acceptability of rTMS.

Conclusions

For TRD patients, augmentative rTMS after the failure of medications significantly increases the effect of antidepressants, and rTMS was a safe strategy with relatively low adverse events and low dropout rate, suggesting that augmentative rTMS is an effective intervention for TRD.

【 授权许可】

   
2014 Liu et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150128174320266.pdf 762KB PDF download
Figure 5. 22KB Image download
Figure 4. 14KB Image download
Figure 3. 24KB Image download
Figure 2. 24KB Image download
Figure 1. 35KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】
  • [1]The Global Burden of Disease: 2004 Update. WHO, Geneva, Switzerland; 2008.
  • [2]Rush AJ, Trivedi M, Fava M: Depression, IV: STAR*D treatment trial for depression. Am J Psychiatry 2003, 160(2):237.
  • [3]Lisanby SH: Electroconvulsive therapy for depression. N Engl J Med 2007, 357(19):1939-1945.
  • [4]Fraser LM, O’Carroll RE, Ebmeier KP: The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT 2008, 24(1):10-17.
  • [5]Rose D, Fleischmann P, Wykes T, Leese M, Bindman J: Patients’ perspectives on electroconvulsive therapy: systematic review. BMJ 2003, 326(7403):1363.
  • [6]Valiengo LC, Bensenor IM, Lotufo PA, Fraguas R Jr, Brunoni AR: Transcranial direct current stimulation and repetitive transcranial magnetic stimulation in consultation-liaison psychiatry. Braz J Med Biol Res 2013, 46(10):815-823.
  • [7]Fitzgerald PB, Brown TL, Daskalakis ZJ: The application of transcranial magnetic stimulation in psychiatry and neurosciences research. Acta Psychiatr Scand 2002, 105(5):324-340.
  • [8]Marangell LB, Martinez M, Jurdi RA, Zboyan H: Neurostimulation therapies in depression: a review of new modalities. Acta Psychiatr Scand 2007, 116(3):174-181.
  • [9]George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P, Hallett M, Post RM: Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995, 6(14):1853-1856.
  • [10]Rossi S, Hallett M, Rossini PM, Pascual-Leone A: Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009, 120(12):2008-2039.
  • [11]McNamara B, Ray JL, Arthurs OJ, Boniface S: Transcranial magnetic stimulation for depression and other psychiatric disorders. Psychol Med 2001, 31(7):1141-1146.
  • [12]Burt T, Lisanby SH, Sackeim HA: Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol 2002, 5(1):73-103.
  • [13]Kozel FA, George MS: Meta-analysis of left prefrontal repetitive transcranial magnetic stimulation (rTMS) to treat depression. J Psychiatr Pract 2002, 8(5):270-275.
  • [14]Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J: Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis. Br J Psychiatry 2003, 182:480-491.
  • [15]Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, Gironell A: Transcranial magnetic stimulation for treating depression. Cochrane Database Syst Rev 2002, 2:CD003493.
  • [16]Couturier JL: Efficacy of rapid-rate repetitive transcranial magnetic stimulation in the treatment of depression: a systematic review and meta-analysis. J Psychiatry Neurosci 2005, 30(2):83-90.
  • [17]Herrmann LL, Ebmeier KP: Factors modifying the efficacy of transcranial magnetic stimulation in the treatment of depression: a review. J Clin Psychiatry 2006, 67(12):1870-1876.
  • [18]Gross M, Nakamura L, Pascual-Leone A, Fregni F: Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies. Acta Psychiatr Scand 2007, 116(3):165-173.
  • [19]Lam RW, Chan P, Wilkins-Ho M, Yatham LN: Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Can J Psychiatry 2008, 53(9):621-631.
  • [20]Allan CL, Herrmann LL, Ebmeier KP: Transcranial magnetic stimulation in the management of mood disorders. Neuropsychobiology 2011, 64(3):163-169.
  • [21]Berlim MT, Van den Eynde F, Daskalakis ZJ: High-frequency repetitive transcranial magnetic stimulation accelerates and enhances the clinical response to antidepressants in major depression: a meta-analysis of randomized, double-blind, and sham-controlled trials. J Clin Psychiatry 2013, 74(2):e122-e129.
  • [22]Berlim MT, Van den Eynde F, Daskalakis ZJ: Efficacy and acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depress Anxiety 2013, 30(7):614-623.
  • [23]Berlim MT, Van den Eynde F, Jeff Daskalakis Z: Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013, 38(4):543-551.
  • [24]Berlim MT, van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ: Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 2014, 44(2):225-239.
  • [25]Slotema CW, Blom JD, Hoek HW, Sommer IE: Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry 2010, 71(7):873-884.
  • [26]Schutter DJ: Quantitative review of the efficacy of slow-frequency magnetic brain stimulation in major depressive disorder. Psychol Med 2010, 40(11):1789-1795.
  • [27]Bretlau LG, Lunde M, Lindberg L, Unden M, Dissing S, Bech P: Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial. Pharmacopsychiatry 2008, 41(2):41-47.
  • [28]Stimpson N, Agrawal N, Lewis G: Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression. Systematic review. Br J Psychiatry 2002, 181:284-294.
  • [29]Trevino K, McClintock SM, McDonald Fischer N, Vora A, Husain MM: Defining treatment-resistant depression: a comprehensive review of the literature. Ann Clin Psychiatry 2014, 26(3):222-232.
  • [30]Bakim B, Uzun UE, Karamustafalioglu O, Ozcelik B, Alpak G, Tankaya O, Cengiz Y, Yavuz BG: The combination of antidepressant drug therapy and high-frequency repetitive transcranial magnetic stimulation in medication-resistant depression. BCP 2012, 22(3):244-253.
  • [31]Higgins JGS: Cochrane Handbook for Systematic Reviews of Intervention 5.2. Cochrane Library, Chichester(GB); 2007.
  • [32]Schmidt FL, Oh IS, Hayes TL: Fixed- versus random-effects models in meta-analysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol 2009, 62(Pt 1):97-128.
  • [33]Citrome L: Number needed to treat: what it is and what it isn’t, and why every clinician should know how to calculate it. J Clin Psychiatry 2011, 72(3):412-413.
  • [34]Higgins JP, Thompson SG: Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558.
  • [35]Chen SJ, Chang CH, Tsai HC, Chen ST, Lin CC: Superior antidepressant effect occurring 1 month after rTMS: Add-on rTMS for subjects with medication-resistant depression. Neuropsychiatr Dis Treat 2013, 9:397-401.
  • [36]Garcia-Toro M, Mayol A, Arnillas H, Capllonch I, Ibarra O, Crespi M, Mico J, Lafau O, Lafuente L: Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression. J Affect Disord 2001, 64(2–3):271-275.
  • [37]Garcia-Toro M, Salva J, Daumal J, Andres J, Romera M, Lafau O, Echevarria M, Mestre M, Bosch C, Collado C, Ibarra O, Aguirre I: High (20-Hz) and low (1-Hz) frequency transcranial magnetic stimulation as adjuvant treatment in medication-resistant depression. Psychiatry Res 2006, 146(1):53-57.
  • [38]Rossini D, Lucca A, Zanardi R, Magri L, Smeraldi E: Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial. Psychiatry Res 2005, 137:1-10.
  • [39]Paillere Martinot ML, Galinowski A, Ringuenet D, Gallarda T, Lefaucheur JP, Bellivier F, Picq C, Bruguiere P, Mangin JF, Riviere D, Willer JC, Falissard B, Leboyer M, Olie JP, Artiges E, Martinot JL: Influence of prefrontal target region on the efficacy of repetitive transcranial magnetic stimulation in patients with medication-resistant depression: a [(18)F]-fluorodeoxyglucose PET and MRI study. Int J Neuropsychopharmacol 2010, 13(1):45-59.
  • [40]Aguirre I, Carretero B, Ibarra O, Kuhalainen J, Martinez J, Ferrer A, Salva J, Roca M, Gili M, Montoya P, Garcia-Toro M: Age predicts low-frequency transcranial magnetic stimulation efficacy in major depression. J Affect Disord 2011, 130(3):466-469.
  • [41]Pallanti S, Bernardi S, Di Rollo A, Antonini S, Quercioli L: Unilateral low frequency versus sequential bilateral repetitive transcranial magnetic stimulation: is simpler better for treatment of resistant depression? Neuroscience 2010, 167(2):323-328.
  • [42]Fitzgerald PB, Hoy K, McQueen S, Maller JJ, Herring S, Segrave R, Bailey M, Been G, Kulkarni J, Daskalakis ZJ: A randomized trial of rTMS targeted with MRI based neuro-navigation in treatment-resistant depression. Neuropsychopharmacology 2009, 34(5):1255-1262.
  • [43]Herbsman T, Avery D, Ramsey D, Holtzheimer P, Wadjik C, Hardaway F, Haynor D, George MS, Nahas Z: More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry 2009, 66(5):509-515.
  文献评价指标  
  下载次数:52次 浏览次数:9次